CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($) $ in Thousands		Total	Redeemable convertible preferred stock	Series E	Series G	Common Stock		Additional paid-in capital	Accumulated other comprehensive income	Accumulated deficit
Balance at beginning of period, redeemable convertible preferred stock (in shares) at Dec. 31, 2019			321,626,778
Balance at beginning of period, redeemable convertible preferred stock at Dec. 31, 2019			$ 913,000
Increase (decrease) in mezzanine equity
Issuance of convertible preferred stock, net of issuance costs (in shares)				48,000,000	43,116,119
Issuance of convertible preferred stock, net of issuance costs				$ 599,000	$ 668,000
Balance at end of period, redeemable convertible preferred stock (in shares) at Dec. 31, 2020			412,742,897
Balance at end of period, redeemable convertible preferred stock at Dec. 31, 2020			$ 2,180,000
Balance at beginning of period, common stock (in shares) at Dec. 31, 2019						224,802,545
Balance at beginning of period at Dec. 31, 2019		$ (97,000)				$ 0		$ 99,000	$ 1,000	$ (197,000)
Increase (decrease) in stockholder's equity
Net income (loss)		7,000								7,000
Shares issued in connection with stock option exercise, net of repurchases (in shares)						4,229,001
Shares issued in connection with stock option exercise, net of repurchases		9,000						9,000
Vesting of early-exercised stock options		1,000						1,000
Change in other comprehensive income		0
Share-based compensation		25,000						25,000
Balance at end of period, common stock (in shares) at Dec. 31, 2020	[1]					229,031,546
Balance at end of period at Dec. 31, 2020		$ (55,000)				$ 0	[1]	134,000	1,000	(190,000)
Balance at end of period, redeemable convertible preferred stock (in shares) at Dec. 31, 2021		0	0
Balance at end of period, redeemable convertible preferred stock at Dec. 31, 2021			$ 0
Increase (decrease) in stockholder's equity
Net income (loss)		$ (3,687,000)								(3,687,000)
Shares issued in connection with stock option exercise, net of repurchases (in shares)	[1]					6,832,725
Shares issued in connection with stock option exercise, net of repurchases		14,000						14,000
Issuance of common stock in connection with Employee Stock Purchase Plan (in shares)	[1]					298,031
Issuance of common stock in connection with Employee Stock Purchase Plan		7,000						7,000
Issuance of common stock in connection with initial public offering, net of issuance costs (in shares)	[1]					56,729,194
Issuance of common stock in connection with initial public offering, net of issuance costs		2,052,000						2,052,000
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (in shares)	[1]					32,133,589
Issuance of common stock upon settlement of restricted stock units, net of shares withheld		0						0
Shares withheld related to net share settlement (in shares)						(11,160,525)
Shares withheld related to net share settlement		(422,000)						(422,000)
Conversion of preferred stock to common stock (in shares)			(412,742,897)			412,742,897	[1]
Conversion of preferred stock to common stock		2,180,000	$ (2,180,000)					2,180,000
Conversion of convertible notes to common stock (in shares)	[1]					137,305,156
Conversion of convertible notes to common stock		5,218,000						5,218,000
Reclassification of warrant liability to stockholders' equity		380,000						380,000
Change in other comprehensive income		0
Vesting of replacement awards issued in connection with acquisition		1,000						1,000
Share-based compensation		1,605,000						1,605,000
Balance at end of period, common stock (in shares) at Dec. 31, 2021	[1]					863,912,613
Balance at end of period at Dec. 31, 2021		7,293,000				$ 0	[1]	11,169,000	1,000	(3,877,000)
Balance at end of period, redeemable convertible preferred stock (in shares) at Dec. 31, 2022			0
Balance at end of period, redeemable convertible preferred stock at Dec. 31, 2022			$ 0
Increase (decrease) in stockholder's equity
Net income (loss)		(1,028,000)							0	(1,028,000)
Shares issued in connection with stock option exercise, net of repurchases (in shares)	[1]					2,318,267
Shares issued in connection with stock option exercise, net of repurchases		6,000				$ 0	[1]	6,000
Issuance of common stock in connection with Employee Stock Purchase Plan (in shares)	[1]					1,907,241
Issuance of common stock in connection with Employee Stock Purchase Plan		16,000						16,000
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (in shares)	[1]					24,613,450
Issuance of common stock upon settlement of restricted stock units, net of shares withheld		(12,000)						(12,000)
Change in other comprehensive income		(1,000)							(1,000)
Share-based compensation		682,000						682,000
Balance at end of period, common stock (in shares) at Dec. 31, 2022	[1]					892,751,571
Balance at end of period at Dec. 31, 2022		$ 6,956,000				$ 0	[1]	$ 11,861,000	$ 0	$ (4,905,000)

[1] The share amounts listed above combine common stock, Class A common stock and Class B common stock. In connection with the completion of our initial public offering, all previously outstanding shares of common stock were reclassified into Class A common stock and Class B common stock. See Note 1 - Description of Business and Summary of Significant Accounting Policies, for further information.